Walter, S. D. http://orcid.org/0000-0003-4157-8928
Hu, Jiarui
Talala, Kirsi
Tammela, Teuvo
Taari, Kimmo
Auvinen, Anssi
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada
the Academy of Finland (Grant No 260931)
the Cancer Society of Finland
Competitive State Research Funding administered by Pirkanmaa University Hospital special responsibility area.
Article History
Received: 13 May 2020
Accepted: 14 July 2021
First Online: 27 July 2021
Declarations
:
: All authors declare they have no conflict of interest, with the exception of Dr Auvinen who has received a lecture honorarium from Novartis.
: An ethics committee review was conducted by Tampere University Hospital (tracking no 95077; R10167). All men who participated in screening gave written consent. For the control arm, registry-based follow-up without contact with study participants does not require consent, according to the Finnish regulations.